Skip to main content
. 2025 Jun 23;23:71. doi: 10.1186/s12959-025-00749-1

Table 3.

Duration (months) of antithrombotic treatment for the index VTE event

n (%) Overall
(N = 600)
Scheduled (intended) duration
 3 months 122 (20.3)
 6 months 267 (44.5)
 9 months 2 (0.3)
 12 months 4 (0.7)
 No scheduled stop date 205 (34.2)
Actual duration
 < 3 months 52 (8.7)
 3–6 months 285 (47.5)
 > 6 months 237 (39.5)
 Unknown (loss of follow-up) 26 (4.3)

Abbreviations n number of patients with variable ,VTE Venous Thromboembolism